Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 277 clinical trials
featured
MBB102073: A clinical research study for subjects with Diabetes Mellitus, Type 2.

MBB102073: A clinical research study for subjects with Diabetes Mellitus, Type 2.

  • 28 views
  • 08 Nov, 2020
  • 1 location
featured
Clinical Trial to evaluate the safety and efficacy of a new medication in patients with Type II Diabetes with Inadequately Controlled Hypertension.

Clinical Trial to evaluate the safety and efficacy of a new medication in patients with Type II Diabetes with Inadequately Controlled Hypertension.

  • 230 views
  • 08 Nov, 2020
  • 1 location
featured
Marfan Syndrome (MFS) Medication Study

Marfan Syndrome (MFS) Medication Study

  • 88 views
  • 08 Nov, 2020
  • 1 location
Efficacy and Safety of Nefecon in Patients With Primary IgA (Immunoglobulin A) Nephropathy

of progressing to end-stage renal disease (ESRD), despite maximum tolerated treatment with renin-angiotensin system (RAS) blockade using angiotensin converting enzyme inhibitors (ACEIs) or

  • 735 views
  • 25 Oct, 2020
  • 154 locations
ACEI/CCB Versus ACEI/DIU Combination Antihypertensive Therapy in Chinese Hypertensive Patients (ACvAD)

the combination of angiotensin-converting enzyme inhibitors (ACEI) or angiotensin receptor blockers (ARB) and calcium antagonists (CCB) or thiazide diuretics (DIU). However, whether the two

antihypertensive therapy
ace inhibitor
angiotensin ii receptor antagonist
calcium
angiotensin
  • 8 views
  • 08 Nov, 2020
  • 1 location
H-Type Hypertension Precision Medicine Trial

. Hypertensive patients demonstrating good tolerance and adherence to angiotensin converting enzyme inhibitor (ACEI) drugs and who have already been genotyped for MTHFR C677T polymorphism may pass over the run

angiotensin converting enzyme
blood pressure diastolic
antihypertensive drugs
systolic blood pressure
ace inhibitor
  • 3 views
  • 08 Nov, 2020
  • 1 location
Patiromer for the Management of Hyperkalemia in Subjects Receiving RAASi Medications for the Treatment of Heart Failure (DIAMOND)

The purpose of this study is to determine if patiromer treatment of subjects who developed hyperkalemia while receiving RAASi medications will result in continued use of RAASi medications in accordance with heart failure (HF) treatment guidelines and thereby decrease the occurrence of the combined endpoint of cardiovascular (CV) death and …

  • 37 views
  • 11 Jan, 2021
  • 459 locations
Study of the Safety and Efficacy of OMS721 in Patients With Immunoglobulin A (IgA) Nephropathy

The purpose of this study is to evaluate the safety and efficacy of OMS721 in patients with IgA nephropathy. The study will assess proteinuria by 24-hour urine protein excretion (UPE) in g/day at 36 weeks from beginning of treatment.

immunoglobulin a
proteinuria
immunoglobulins
glomerular filtration rate
  • 243 views
  • 03 Jun, 2019
  • 29 locations
Twice Against Thrice-weekly Hemodialysis

Hemodialysis is the most worldwide prescribed renal replacement therapy for patients with end-stage renal disease. The frequency of sessions per week remains a debatable issue. In the majority of developed Western and Asian countries, patients on chronic hemodialysis are undergoing three dialysis sessions weekly. In developing countries and some developed …

hypertension
chronic hemodialysis
renal replacement therapy
chronic renal failure
  • 23 views
  • 22 Oct, 2020
  • 1 location
Angiotensin-(1-7) and Energy Expenditure in Human Obesity

The objective of this study is to better define the role of the hormone angiotensin-(1-7) in energy balance. We will test the overall hypothesis that angiotensin-(1-7) increases resting energy

body mass index
  • 94 views
  • 15 Oct, 2020
  • 1 location